Почетна › Неуробластом › Minesota
Kliničke studije za Неуробластом u državi Minesota
9 studija za Неуробластом traži učesnike na lokacijama u državi Minesota.
Gradovi u državi Minesota
Zvanični tekst studije (na engleskom)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Masonic Cancer Center, University of Minnesota, Minneapolis
Тражи се учесникФаза 2
До 30 година · Оба пола · Ажурирано 27. 10. 2026. · NCT02605421International PPB/DICER1 Registry
- Children's Minnesota, Minneapolis
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
0 Minutes – 100 Years · Оба пола · Ажурирано 26. 10. 2026. · NCT03382158Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
Тражи се учесникОпсервациона студија
Узраст од 3 до 25 · Оба пола · Ажурирано 14. 9. 2026. · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Children's Hospital and Clinics of Minnesota, Minneapolis
Тражи се учесникФаза 2
До 22 година · Оба пола · Ажурирано 4. 9. 2026. · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
Тражи се учесникФаза 2
12 Months – 21 Years · Оба пола · Ажурирано 12. 8. 2026. · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 19. 5. 2026. · NCT04901702Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.